Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News
VIDEO: Lifetime disruptor ‘just getting started’ in quest to elevate care for IBD patients
Marla C. Dubinsky, MD, winner of the 2023 Healio Lifetime Disruptor Award, was first inspired to “disrupt the space” after witnessing patients with inflammatory bowel disease become frustrated with lack of support and access to care.
'Our patients deserve better': AMA adopts policies to protect health care access
The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Hot flash severity may predict metabolic-associated liver disease
BOSTON — Midlife women reporting bothersome hot flashes are more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease regardless of hormone therapy use, according to a speaker.
AGA recommends endoscopic eradication vs. surveillance for BE with high-grade dysplasia
In a new clinical practice guideline, the AGA provides evidence-based recommendations for use of endoscopic eradication therapy in the management of Barrett’s esophagus, accounting for the presence of dysplasia and other scenarios.
VIDEO: Studies show no increased risk of cancer, CV events with JAK inhibitors
In this video, Raymond Cross, MD, spoke with Healio about several studies assessing the safety and efficacy of JAK inhibitors in patients with IBD presented at Digestive Disease Week 2024.
Bulevirtide monotherapy ‘may prevent decompensation but not HCC’ in HDV, cirrhosis
Over 2 years, bulevirtide monotherapy reduced the risk for decompensation and mortality, but not hepatocellular carcinoma, among patients with hepatitis D virus and compensated cirrhosis compared with untreated patients.
AMA adopts policy advocating for Medicaid expansion
The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.
AMA: Drug, device sponsors need to include women, LGBTQ+ patients in trials
The AMA announced a new policy that supports requirements for drug and device sponsors to develop diversity action plans so that women and sexual and gender minorities are adequately represented in their clinical trials.
MASH patients with high BMI, weight respond ‘slightly better’ to higher Rezdiffra dose
Patients with metabolic dysfunction-associated steatohepatitis who weigh more than 100 kg or a BMI more than 35 kg/m² had “slightly better” response with a 100 mg dose of Rezdiffra, according to data presented at EASL Congress.
Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis
Difficult-to-treat psoriatic arthritis was common in a large, real-life cohort, with key risk factors including extensive psoriasis, higher BMI and a history of inflammatory bowel disease, according to data published in Rheumatology.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read